Patsalos-Fox Michael 4
Research Summary
AI-generated summary
Cognizant (CTSH) Director Michael Patsalos‑Fox Receives Award
What Happened
- Michael Patsalos‑Fox, a director of Cognizant Technology Solutions (CTSH), received awards of deferred restricted stock units (29.368 units) and restricted stock units (14.664 units) on February 26, 2026. Both awards were granted at $0.00 (typical for RSU grants); total units granted = 44.032. These are not open‑market purchases or sales — they are equity compensation awards.
Key Details
- Transaction date: 2026-02-26; Form 4 filed: 2026-03-02 (timely — filed within the required two business days).
- Grants: 29.368 deferred RSUs (footnote F1/F2) and 14.664 RSUs (footnote F3/F4); grant price reported $0.00.
- Vesting/settlement:
- Deferred RSUs are fully vested but will be settled (paid in shares) upon the reporting person's termination of Board service (F2). They reflect dividend equivalent rights accrued on prior deferred RSUs (F1).
- The restricted stock units will vest fully on June 3, 2026 and reflect dividend equivalents on prior RSUs (F3/F4).
- Shares owned after the transaction: not specified in the provided excerpt of the filing.
- Transaction type code: A = Award/Grant (derivative awards). No sale or purchase reported.
Context
- These grants are equity compensation and do not represent an open‑market buy or sell. The economic value to the insider depends on Cognizant’s stock price at settlement/vesting. Deferred RSUs that are already vested but payable only upon leaving the board are common for directors and are generally administrative rather than a market sentiment signal.